首页> 外文OA文献 >Phase II Trial of Suramin, Leuprolide, and Flutamide in Previously Untreated Metastatic Prostate Cancer

【2h】

Phase II Trial of Suramin, Leuprolide, and Flutamide in Previously Untreated Metastatic Prostate Cancer

机译：苏拉明，亮丙瑞林和氟他胺在既往未经治疗的转移性前列腺癌中的II期临床试验

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
A. Dawson; William D. Figg; Michael R. Cooper; Oliver Sartor; Raymond C. Bergan; Adrian M. Senderowicz; Seth M. Steinberg; Anne Tompkins; Betsy Weinberger; Edward A. Sausville; Eddie Reed; Charles E. Myers;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer. [J] . Dawson NA, Figg WD, Cooper MR, Journal of Clinical Oncology . 1997,第4期

机译：苏拉明，亮丙瑞林和氟他胺在先前未经治疗的转移性前列腺癌中的II期试验。
2. Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone. [J] . Small EJ, Meyer M, Marshall ME, Journal of Clinical Oncology . 2000,第7期

机译：苏拉明对有症状激素难治性前列腺癌患者的治疗：比较苏拉明加氢化可的松与安慰剂加氢化可的松的一项随机III期试验结果。
3. 7016 Degarelix versus leuprolide in prostate cancer patients: new prostate-specific antigen data from a phase III trial (CS21) [J] . B.Tombal, K.Miller, L.Boccon-Gibod, European Journal of Cancer Supplements . 2009,第2期

机译：7016 Degarelix与亮丙瑞林在前列腺癌患者中的关系：来自III期试验（CS21）的新前列腺特异性抗原数据
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Clinical predictive value of pre-clinical cancer models: A study of the predictive value of the in vitro cell line, human xenograft and murine allograft pre-clinical cancer models for phase II clinical trials of cytotoxic cancer drugs [D] . Voskoglou-Nomikos, Theodora 2001

机译：临床前癌症模型的临床预测价值：体外细胞系，人异种移植和小鼠同种异体移植临床前癌症模型对细胞毒性癌症药物II期临床试验的预测价值研究
6. Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: study protocol for a multicenter randomized phase II trial (the OCUU-CRPC study) [O] . Taro Iguchi, Satoshi Tamada, Minoru Kato, 2019

机译：恩杂鲁胺与氟他胺治疗比卡鲁胺联合雄激素阻断治疗后去势抵抗性前列腺癌：一项多中心随机II期试验的研究方案（OCUU-CRPC研究）
7. A Phase II Trial of Flavopiridol (NSC #649890) in Patients with Previously Untreated Metastatic Androgen-Independent Prostate Cancer [O] . Glenn Liu, David R. Gandara, Primo N. Lara, 2004

机译：在先前未经处理的转移性雄激素无关的前列腺癌患者中黄哌啶（NSC＃649890）的II期试验

Phase II Trial of Suramin, Leuprolide, and Flutamide in Previously Untreated Metastatic Prostate Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅